Back to the search results

Universitätsklinikum Heidelberg: Campus

Universitätsklinikum Heidelberg: Campus
Universitätsklinikum Heidelberg: Campus

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221-56-0
Fax: 06221-56-4888
Mail: ed.grebledieh-inu.dem@tcatnoc

  • Number of beds: 1.421
  • Number of specialist departments: 60
  • Number of inpatient cases: 54.600
  • Number of partial inpatient cases: 9.763
  • Number of outpatient cases: 1.017.809
  • Hospital owners: Universitätsklinikum Heidelberg
  • Type of provider: öffentlich
  • University Hospital
  • Academic teaching hospital
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Koronare Herzkrankheit (KHK)

Beitritt am 02.12.2005, Abteilung Innere Medizin III (Kardiologie, Angiologie, Pneumologie)

Quantity performed 54
Exception? No exception
Quantity performed 540
Exception? No exception
Quantity performed 47
Exception? No exception
Quantity performed 97
Exception? No exception
Quantity performed 350
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 54
Quantity forecast year: 49
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 540
Quantity forecast year: 527
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 47
Quantity forecast year: 73
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 97
Quantity forecast year: 112
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 350
Quantity forecast year: 358
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 48
Quantity forecast year: 54
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 694
Quantity forecast year: 543
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ03 Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
CQ02 Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases
CQ04 Measures for quality assurance in the implementation of proton therapy in hospitals for the indication rectal carcinoma
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ08 Measures for quality assurance of cardiac surgery care in children and adolescents according to Article 136, para. 1, sentence 1, no. 2 of the SGB V
CQ24 Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
801 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
514 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
450 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Arzneimittelanamnese Schulung

09.03.2023

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Bereitstellung zur Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

26 Ausbildungsplätze, Schulleiter: Andreas Motzkus

Comment

Hebamme B. Sc.: Das UKHD hat 45 Studienplätze in Kooperation mit der Hochschule Ludwigshafen: Duales Studium Hebammenwissenschaft | Hochschule für Wirtschaft und Gesellschaft Ludwigshafen (hwg-lu.de)

Comment

65 Ausbildungsplätze, Schulleiterin: Barbara Suppé

Comment

Gesundheits- und Krankenpflegehelfer und Gesundheits- und Krankenpflegehelferin: 15 Ausbildungsplätze, Schulleiter: Burkhard Götsch

Comment

30 Ausbildungsplätze, Schulleiterin: Susanne Janknecht

Comment

60 Ausbildungsplätze, Schulleiterin: Hildegard Hack

Comment

75 Ausbildungsplätze, Schulleiterin: Stephanie Biedenstein

Comment

75 Ausbildungsplätze, Schulleiter: Andreas Motzkus

Comment

12 Ausbildungsplätze, Schulleiterin: Birgit Wahl

Comment

415 Ausbildungsplätze, Schulleiter: Burkhard Götsch

Comment

Das UKHD hat 10 Studienplätze in Kooperation mit der Hochschule für Wirtschaft und Gesellschaft Ludwigshafen: https://www.hwg-lu.de/studium/bachelor/pflege-studieren

Prof. Dr. med. Eike Martin

Emeritus

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-36616
Mail: ed.grebledieh-inu.dem@rehcerpsreuftneitap

Dr. med. Markus Thalheimer

Leiter QM/MC

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-7639
Mail: ed.grebledieh-inu.dem@cmmq.nimdA

Dr. med. Christoph Arens

Zentralbereich Medizinstrategie, Leiter Stabsstelle Medizinisches Qualitäts- und Risikomanagement (ab 15.07.2023)

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-0
Mail: ed.grebledieh-inu.dem@snera.hpotsirhc

Dr. med. Markus Thalheimer

Leiter QM/MC

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-7639
Mail: ed.grebledieh-inu.dem@CMMQ.nimdA

PD Dr. med. Christian Brandt

Leitung Sektion Krankenhaus- und Umwelthygiene

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-32207
Mail: ed.grebledieh-inu.dem@tdnarb.naitsirhc

Prof. Dr. med. Ingo Autenrieth

Leitender Ärztlicher Direktor

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-4800
Mail: ed.grebledieh-inu.dem@DeAL

Über die Pforten der jeweiligen Klinik

Vermittlung

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-0
Mail: ed.grebledieh-inu.dem@tcatnoc

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221-56-0
Fax: 06221-56-4888
Mail: ed.grebledieh-inu.dem@tcatnoc

Edgar Reisch

Pflegedirektor, Geschäftsführer KSG und AfG

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-8989
Mail: ed.grebledieh-inu.dem@hcsier.ragde

Dipl.-Kfm. Hartmut Masanek

komm. Kaufm. Direktor, 01.08.2019-31.03.2020

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-7000
Mail: ed.grebledieh-inu.dem@noitkeriD-ehcsinneamfuaK

Katrin Erk

Kaufm. Direktorin, stellv. Vorstandsvors., ab 01.04.2020

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-7000
Mail: ed.grebledieh-inu.dem@noitkeriD-ehcsinneamfuaK

Prof. Dr. med. Ingo B. Autenrieth

Leitender Ärztlicher Direktor

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-4811
Mail: ed.grebledieh-inu.dem@deaL

Prof. Dr. med. Matthias Karck

komm. Ltd. Ärztlicher Direktor, Vorstandsvors., 01.11.2019-31.03.2020

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-4811
Mail: ed.grebledieh-inu.dem@deal

Prof. Dr. med. Ingo B. Autenrieth

Ltd. Ärztlicher Direktor, Vorstandsvors. ab 01.04.2020

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-4811
Mail: ed.grebledieh-inu.dem@deal

Prof. Dr. med. Dr. rer. nat. Jürgen Debus

stellv. Leitender Ärztlicher Direktor (ab 01.11.2022)

Im Neuenheimer Feld 672
69120 Heidelberg

Phone: 06221 -56-8201
Mail: ed.grebledieh-inu.dem@subed.negreuj

IK: 260820466

Location number: 771700000

Old location number: 771700000